REVVITY, INC Stock Issued During Period, Value, Employee Stock Purchase Plan
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- REVVITY, INC stock issued during period, value, employee stock purchase plan for the quarter ending 2026-07-05 was $1.18M.
- REVVITY, INC stock issued during period, value, employee stock purchase plan for the quarter ending 2026-04-05 was $1.23M, a 3.38% decline year-over-year.
- REVVITY, INC stock issued during period, value, employee stock purchase plan for the quarter ending 2025-09-28 was $1.39M.
- REVVITY, INC stock issued during period, value, employee stock purchase plan for the quarter ending 2025-03-30 was $1.27M.
- REVVITY, INC stock issued during period, value, employee stock purchase plan for fiscal 2025 was $2.66M, a 86.34% increase from fiscal 2024.
- REVVITY, INC stock issued during period, value, employee stock purchase plan for fiscal 2024 was $1.43M, a 54.41% decline from fiscal 2023.
- REVVITY, INC stock issued during period, value, employee stock purchase plan for fiscal 2023 was $3.13M, a 24.93% decline from fiscal 2023.
- REVVITY, INC stock issued during period, value, employee stock purchase plan for fiscal 2023 was $4.17M, a 14.99% increase from fiscal 2022.
| Period end | Stock Issued During Period, Value, Employee Stock Purchase Plan 3 month | Stock Issued During Period, Value, Employee Stock Purchase Plan 12 month |
|---|---|---|
| 2026-07-05 | $1.18M 10-Q · filed 2026-08-11 | |
| 2026-04-05 | $1.23M 10-Q · filed 2026-08-11 | |
| 2025-12-28 | $2.66M 10-K · filed 2026-02-24 | |
| 2025-09-28 | $1.39M 10-Q · filed 2025-11-04 | |
| 2025-03-30 | $1.27M 10-Q · filed 2026-08-11 | |
| 2024-12-29 | $1.43M 10-K · filed 2026-02-24 | |
| 2024-09-29 | $0.00 10-Q · filed 2025-11-04 | |
| 2024-06-30 | $1.43M 10-Q · filed 2025-11-04 | |
| 2023-12-31 | $3.13M 10-K · filed 2026-02-24 | |
| 2023-07-02 | $1.64M 10-Q · filed 2024-11-06 | |
| 2023-01-01 | $4.17M 10-K · filed 2025-02-25 | |
| 2022-10-02 | $31.00K 10-Q · filed 2023-11-07 | |
| 2022-07-03 | $1.83M 10-Q · filed 2023-11-07 | |
| 2022-01-02 | $3.63M 10-K · filed 2024-02-27 | |
| 2021-10-03 | $0.00 10-Q · filed 2022-11-14 | |
| 2021-07-04 | $1.62M 10-Q · filed 2022-11-14 | |
| 2021-04-04 | $8.00K 10-Q · filed 2022-11-14 | |
| 2021-01-03 | $4.10M 10-K · filed 2023-03-01 | |
| 2020-10-04 | $26.00K 10-Q · filed 2020-11-10 | |
| 2020-07-05 | $1.30M 10-Q · filed 2021-11-09 | |
| 2020-04-05 | $1.26M 10-Q · filed 2021-11-09 | |
| 2019-12-29 | $2.78M 10-K · filed 2022-03-03 | |
| 2019-09-29 | $12.00K 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $1.40M 10-Q · filed 2020-11-10 | |
| 2019-03-31 | $1.39M 10-Q · filed 2020-11-10 | |
| 2018-12-30 | $1.49M 10-K · filed 2021-03-02 | |
| 2018-07-01 | $1.48M 10-Q · filed 2019-11-05 | |
| 2018-04-01 | $0.00 10-Q · filed 2019-08-06 | |
| 2017-12-31 | $2.47M 10-K · filed 2020-02-25 | |
| 2017-01-01 | $2.46M 10-K · filed 2019-02-26 | |
| 2016-01-03 | $3.69M 10-K · filed 2018-02-27 | |
| 2014-12-28 | $2.54M 10-K · filed 2017-02-28 | |
| 2013-12-29 | $2.73M 10-K · filed 2016-03-01 | |
| 2012-12-30 | $1.32M 10-K · filed 2015-02-24 | |
| 2012-01-01 | $2.20M 10-K · filed 2014-02-25 | |
| 2011-01-02 | $1.87M 10-K · filed 2013-02-26 | |
| 2010-01-03 | $3.14M 10-K · filed 2012-02-28 | |
| 2008-12-28 | $2.18M 10-K · filed 2011-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $30.436B | 30.62 | |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |